From negative factor to a critical role in virus pathogenesis: the changing fortunes of Nef

References

1. Aderem A. 1992; The MARCKS brothers: a family of protein kinase C substrates. Cell 71:713–716
   [Google Scholar]
2. Ahmad N., Venkatesan S. 1988; Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. Science 241:1481–1485
   [Google Scholar]
3. Aiken C., Trono D. 1995; Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. Journal of Virology 69:5048–5056
   [Google Scholar]
4. Aiken C., Konner J., Landau N. R., Lenburg M. E., Trono D. 1994; Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76:853–864
   [Google Scholar]
5. Aiken C., Krause L., Chen Y., Trono D. 1996; Mutational analysis of HIV-1 Nef: identification of two mutants that are temperature-sensitive for CD4 downregulation. Virology 217:293–300
   [Google Scholar]
6. Aldrovandi G. M., Zack J. A. 1996; Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-Hu mice. Journal of Virology 70:1505–1511
   [Google Scholar]
7. Allan J. S., Coligan J. E., Lee T., McLane M. F., Kanki P. J., Groopman J. E., Essex M. 1985; A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Science 230:810–813
   [Google Scholar]
8. Almond N., Kent K., Cranage M., Rud E., Clarke B., Stott E. J., Beale J. 1995; Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345:1342–1344
   [Google Scholar]
9. Anderson S., Shugars D. C., Swanstrom R., Garcia J. V. 1993; Nef from primary isolates of human immunodeficiency vims type 1 suppresses surface CD4 expression in human and mouse T cells. Journal of Virology 67:4923–4931
   [Google Scholar]
10. Anderson S. J., Lenburg M., Landau N. R., Garcia J. V. 1994a; The cytoplasmic domain of CP4 is sufficient for its down-regulation from the cell surface by human immunodeficiency vims type 1 Nef. Journal of Virology 68:3092–3101
    [Google Scholar]
11. Anderson S. J., Levin S. D., Perlmutter R. M. 1994b; Involvement of the protein tyrosine kinase p56lck in T cell signaling and thymocyte development. Advances in Immunology 56:151–178
    [Google Scholar]
12. Baba T. W., Jeong Y. S., Penninck D., Bronson R., Greene M. F., Ruprecht R. M. 1995; Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267:1820–1825
    [Google Scholar]
13. Backer J. M., Mendola C. E., Fairhurst J. L., Kovesdi I. 1991; The HIV-1 nef protein does not have guanine nucleotide binding, GTPase, or autophosphorylating activities. AIDS Research and Human Retroviruses 7:1015–1020
    [Google Scholar]
14. Bandres J. C., Ratner L. 1994; Human immunodeficiency vims type 1 Nef protein down-regulates transcription factors nf_k b and AP-1 in human T cells in vitro after T-cell receptor stimulation. Journal of Virology 68:3243–3249
    [Google Scholar]
15. Bandres J. O., Luria S., Ratner L. 1994; Regulation of human immunodeficiency vims Nef protein by phosphorylation. Virology 201:157–161
    [Google Scholar]
16. Bandres J. C., Shaw A. S., Ratner L. 1995; HIV-1 Nef protein downregulation of CD4 surface expression: relevance of the Lck binding domain of CD4. Virology 207:338–341
    [Google Scholar]
17. Baser M., Werner A., Bannert N., Metzner K., Kurth R. 1995; HIV suppression by interleukin-16. Nature 378:563–564
    [Google Scholar]
18. Baur A. S., Sawai E. T., Dazin P., Fantl W. J., Cheng-Mayer C., Peterlin B. M. 1994; HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1:373–384
    [Google Scholar]
19. Benichou S., Bomsel M., Bodeus M., Durand H., Doute M., Letourneur F., Camonis J., Benarous R. 1994; Physical interaction of the HIV-1 Nef protein with β-COP, a component of non-clathrin-coated vesicles essential for membrane traffic. Journal of Biological Chemistry 269:30073–30076
    [Google Scholar]
20. Benkirane M., Corbeau P., Housset V., Devaux C. 1993; An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provims transcription in HIV-infected T cells. EMBO Journal 12:4909–4921
    [Google Scholar]
21. Benson R. E., Sanfridson A., Ottinger J. S., Doyle C., Cullen B. R. 1993; Downregulation of cell-surface CD4 expression by simian immunodeficiency vims nef prevents viral superinfection. Journal of Experimental Medicine 177:1561–1566
    [Google Scholar]
22. Binninger D., Ennen J., Bonn D., Norley S. G., Kurth R. 1991; Mutational analysis of the simian immunodeficiency vims SIVmac nef gene. Journal of Virology 65:5237–5243
    [Google Scholar]
23. Bodeus M., Mariecardine A., Bougeret C., Ramos-Morales F., Benarous R. 1995; In vitro binding and phosphorylation of human immunodeficiency vims type 1 Nef protein by serine/threonine protein kinase. Journal of General Virology 76:1337–1344
    [Google Scholar]
24. Brady H. J. M., Pennington D. J., Miles C. G., Dzierzak E. A. 1993; CD4 cell surface downregulation in HIV-1 nef transgenic mice is a consequence of intracellular sequestration. EMBO Journal 12:4923–4932
    [Google Scholar]
25. Cheingsong Popov R., Panagiotidi C., Ali M., Bowcock S., Watkins P., Aronstam A., Wassef M., Weber J. 1990; Antibodies to HIV-1 nef (p27): prevalence, significance, and relationship to seroconversion. AIDS Research and Human Retroviruses 6:1099–1105
    [Google Scholar]
26. Cheng Mayer C., lannello P., Shaw K., Luciw P. A., Levy J. A. 1989; Differential effects of nef on HIV replication: implications for viral pathogenesis in the host. Science 246:1629–1632
    [Google Scholar]
27. Chowers M. Y., Spina C. A., Kwoh T. J., Fitch N. J. S., Richman D. D., Guatelli J. C. 1994; Optimal infectivity in vitro of human immunodeficiency vims type 1 requires an intact nef gene. Journal of Virology 68:2906–2914
    [Google Scholar]
28. Chowers M. Y., Pandori M. W., Spina C. A., Richman D. D., Guatelli J. C. 1995; The growth advantage conferred by HIV-1 Nef is determined at the level of viral DNA formation and is independent of CD4 downregulation. Virology 212:451–457
    [Google Scholar]
29. Coates K., Harris M. 1995; The human immunodeficiency vims type 1 Nef protein functions as a protein kinase C substrate in vitro . Journal of General Virology 76:837–844
    [Google Scholar]
30. Collette Y., Chang H. L., Cerdan C., Chambost H., Algarte M., Mawas C., Imbert J., Burny A., Olive D. 1996a; Specific Thl cytokine down-regulation associated with primary clinically derived human immunodeficiency vims type 1 nef gene-induced expression. Journal of Immunology 156:360–370
    [Google Scholar]
31. Collette Y., Dutartre H., Benziane A., Ramosmorales F., Benarous R., Harris M., Olive D. 1996b; Physical and functional interaction of Nef with Lck: HIV-1 Nef-induced T-cell signaling defects. Journal of Biological Chemistry 271:6333–6341
    [Google Scholar]
32. Culmann B., Gomard E., Kieny M. P., Guy B., Dreyfus F., Saimot A. G., Sereni D., Sicard D., Levy J. P. 1991; Six epitopes reacting with human cytotoxic CD8 + T cells in the central region of the HIV-1 NEF protein. Journal of Immunology 146:1560–1565
    [Google Scholar]
33. Daniel M. D., Kirchhoff F., Czajak S. C., Sehgal P. K., Desrosiers R. C. 1992; Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938–1941
    [Google Scholar]
34. Davies A. H. 1995; Advances in the use of recombinant baculoviruses for the expression of heterologous proteins. Current Opinion in Biotechnology 6:543–547
    [Google Scholar]
35. De S. K., Marsh J. W. 1994; HIV-1 Nef inhibits a common activation pathway in NIH-3T3 cells. Journal of Biological Chemistry 269:6656–6660
    [Google Scholar]
36. Deacon N. J., Tsykin A., Solomon A., Smith K., Ludfordmenting M., Hooker D. J., McPhee D. A., Greenway A. L., Ellett A., Chatfield C., Lawson V. A., Crowe S., Maerz A., Sonza S., Learmont J., Sullivan J. S., Cunningham A., Dwyer D., Dowton D., Mills J. 1995; Genomic structure of an attenuated quasispecies of HIV-1 from a blood transfusion donor and recipients. Science 270:988–991
    [Google Scholar]
37. Delassus S., Cheynier R., Wain Hobson S. 1991; Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro . Journal of Virology 65:225–231
    [Google Scholar]
38. de Ronde A., Klaver B., Keulen W., Smit L., Goudsmit J. 1992; Natural HIV-1 NEF accelerates virus replication in primary human lymphocytes. Virology 188:391–395
    [Google Scholar]
39. Dever T. E., Glynias M. J., Merrick W. C. 1987; GTP-binding domain: three consensus sequence elements with distinct spacing. Proceedings of the National Academy of Sciences, USA 84:1814–1818
    [Google Scholar]
40. Du Z., Lang S. M., Sasseville V. G., Lackner A. A., Ilyinskil P. O., Daniel M. D., Jung J. U., Desrosiers R. C. 1995; Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 82:665–674
    [Google Scholar]
41. Fiedler K., Simons K. 1995; The role of N-glycans in the secretory pathway. Cell 81:309–312
    [Google Scholar]
42. Fisher A. G., Ratner L., Mitsuya H., Marselle L. M., Harper M. E., Broder S., Gallo R. C., Wong-Staal F. 1986; Infectious mutants of HTLVX-III with changes in the 3′ region and markedly reduced cytopathic effects. Science 233:655–659
    [Google Scholar]
43. Foster J. L., Anderson S. J., Frazier A. L. B., Garcia J. V. 1994; Specific suppression of human CD4 surface expression by Nef from the pathogenic simian immunodeficiency virus SIVmac239(open). Virology 201:373–379
    [Google Scholar]
44. Franchini G., Robert-Guroff M., Ghrayeb J., Chang N. T., Wong-Staal F. 1986; Cytoplasmic localization of the HTLVX-III 3′ orf protein in cultured T cells. Virology 155:593–599
    [Google Scholar]
45. Freund J., Kellner R., Houthaeve T., Kalbitzer H. R. 1994a; Stability and proteolytic domains of Nef protein from human immunodeficiency virus (HIV) type 1. European Journal of Biochemistry 221:811–819
    [Google Scholar]
46. Freund J., Kellner R., Konvalinka J., Wolber V., Krausslich H. G., Kalbitzer H. R. 1994b; A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease. European Journal of Biochemistry 223:589–593
    [Google Scholar]
47. Fujii Y., Nishino Y., Nakaya T., Tokunaga K., Ikuta K. 1993; Expression of human immunodeficiency virus type 1 Nef antigen on the surface of acutely and persistently infected human T cells. Vaccine 11:1240–1246
    [Google Scholar]
48. GaedigkNitschko K., Schon A., Wachinger G., Erfle V., Kohleisen B. 1995; Cleavage of recombinant and cell derived human immunodeficiency virus 1 (HIV-1) Nef protein by HIV-1 protease. FEBS Letters 357:275–278
    [Google Scholar]
49. Gallimore A., Cranage M., Cook N., Almond N., Bootman J., Rud E., Silvera P., Dennis M., Corcoran T., Stott J., McMichael A., Gotch F. 1995; Early suppression of SIV replication by CD8 + nef-specific cytotoxic T cells in vaccinated macaques. Nature Medicine 1:1167–1173
    [Google Scholar]
50. Garcia J. V., Miller A. D. 1991; Serine phosphorylation-independent downregulation of cell-surface CD4 by nef . Nature 350:508–511
    [Google Scholar]
51. Garcia J. V., Alfano J., Miller A. D. 1993; The negative effect of human immunodeficiency virus type 1 Nef on cell surface CD4 expression is not species specific and requires the cytoplasmic domain of CD4. Journal of Virology 67:1511–1516
    [Google Scholar]
52. Goldsmith M. A., Warmerdam M. T., Atchison R. E., Miller M. D., Greene W. C. 1995; Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. Journal of Virology 69:4112–4121
    [Google Scholar]
53. Greenway A. L., McPhee D. A., Grgacic E., Hewish D., Lucantoni A., Macreadie I., Azad A. 1994; Nef 27, but not the Nef 25 isoform of human immunodeficiency virus-type 1 pNL4.3 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cells. Virology 198:245–256
    [Google Scholar]
54. Greenway A., Azad A., McPhee D. 1995; Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. Journal of Virology 69:1842–1850
    [Google Scholar]
55. Grzesiek S., Bax A., Clore G. M., Gronenborn A. M., Hu J., Kaufman J., Palmer I., Stahl S. J., Wingfield P. T. 1996; The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding site for the SH3 domain of Hck tyrosine protein kinase. Nature Structural Biology 3:340–345
    [Google Scholar]
56. Guy B., Kieny M. P., Riviere Y., Le Peuch C., Dott K., Girard M., Montagnier L., Lecocq J. 1987; HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 330:266–269
    [Google Scholar]
57. Hadida F., Parrot A., Kieny M. P., Sadat Sowti B., Mayaud C., Debre P., Autran B. 1992; Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis. Journal of Clinical Investigation 89:53–60
    [Google Scholar]
58. Hammes S. R., Dixon E. P., Malim M. H., Cullen B. R., Greene W. C. 1989; Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. Proceedings of the National Academy of Sciences, USA 86:9549–9553
    [Google Scholar]
59. Harris M. 1995; The role of myristoylation in the interactions between human immunodeficiency virus type 1 nef and cellular proteins. Biochemical Society Transactions 23:557–561
    [Google Scholar]
60. Harris M., Coates K. 1993; Identification of cellular proteins that bind to the human immunodeficiency virus type 1 nef gene product in vitro: a role for myristylation. Journal of General Virology 74:1581–1589
    [Google Scholar]
61. Harris M. P. G., Neil J. C. 1994; Myristoylation-dependent binding of HIV-1 Nef to CD4. Journal of Molecular Biology 241:136–142
    [Google Scholar]
62. Harris M., Hislop S., Patsilinacos P., Neil J. C. 1992; In vivo derived HIV-1 nef gene products are heterogeneous and lack detectable nucleotide binding activity. AIDS Research and Human Retroviruses 8:537–543
    [Google Scholar]
63. Hodge D. R., Chen Y. M. A., Samuel K. P. 1995; Oligomerization of the HIV type 2 Nef protein: mutational analysis of the heptad leucine repeat motif and cysteine residues. AIDS Research and Human Retroviruses 11:65–79
    [Google Scholar]
64. Huang Y., Zhang L., Ho D. D. 1995a; Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection. Journal of Virology 69:93–100
    [Google Scholar]
65. Huang Y., Zhang L., Ho D. D. 1995b; Biological characterization of nef in long-term survivors of human immunodeficiency virus type 1 infection. Journal of Virology 69:8142–8146
    [Google Scholar]
66. Jamieson B. D., Aldrovandi G. M., Planelles V., Jowett J. B. M., Gao L., Bloch L. M., Chen I. S. Y., Zack J. A. 1994; Requirement of human immunodeficiency virus type I nef for in vivo replication and pathogenicity. Journal of Virology 68:3478–3485
    [Google Scholar]
67. Kaminchik J., Bashan N., Pinchasi D., Amit B., Sarver N., Johnston M. I., Fischer M., Yavin Z., Gorecki M., Panet A. 1990; Expression and biochemical characterization of human immunodeficiency virus type 1 nef gene product. Journal of Virology 64:3447–3454
    [Google Scholar]
68. Kaminchik J., Margalit R., Yaish S., Drummer H., Amit B., Sarver N., Gorecki M., Panet A. 1994; Cellular distribution of HIV type 1 Nef protein: identification of domains in Nef required for association with membrane and detergent-insoluble cellular matrix. AIDS Research and Human Retroviruses 10:1003–1010
    [Google Scholar]
69. Kestler H. W., Ringler D. J., Mori K., Panicali D. L., Sehgal P. K., Daniel M. D., Desrosiers R. C. 1991; Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651–662
    [Google Scholar]
70. Kienzle N., Bachmann M., Muller W. E., Mueller-Lantzsch N. 1992; Expression and cellular localization of the Nef protein from human immunodeficiency virus-1 in stably transfected B-cells. Archives of Virology 124:123–132
    [Google Scholar]
71. Kienzle N., Freund J., Kalbitzer H. R., Mueller-Lantzsch N. 1993; Oligomerization of the nef protein from human immunodeficiency virus (HIV) type 1. European Journal of Biochemistry 214:451–457
    [Google Scholar]
72. Kim S., Ikeuchi K., Byrn R., Groopman J., Baltimore D. 1989; Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, USA 86:9544–9548
    [Google Scholar]
73. Kirchoff F., Greenough T. C., Brettler D. B., Sullivan J. L., Desrosiers R. C. 1995; Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. New England Journal of Medicine 332:228–232
    [Google Scholar]
74. Kohleisen B., Neumann M., Herrmann R., Brack Werner R., Krohn K. J., Ovod V., Ranki A., Erfle V. 1992; Cellular localization of Nef expressed in persistently HIV-1-infected low-producer astrocytes. AIDS 6:1427–1436
    [Google Scholar]
75. Laurent A. G., Hovanessian A. G., Riviere Y., Krust B., Regnault A., Montagnier L., Findeli A., Kieny M. P., Guy B. 1990; Production of a non-functional nef protein in human immunodeficiency virus type 1-infected CEM cells. Journal of General Virology 71:2273–2281
    [Google Scholar]
76. Lee C. H., Leung B., Lemmon M. A., Zheng J., Cowburn D., Kuriyan J., Saksela K. 1995; A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO Journal 14:5006–5015
    [Google Scholar]
77. Letourneur F., Klausner R. D. 1992; A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell 69:1143–1157
    [Google Scholar]
78. Luciw P. A., Cheng-Mayer C., Levy J. A. 1987; Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication. Proceedings of the National Academy of Sciences, USA 84:1434–1438
    [Google Scholar]
79. Luria S., Chambers I., Berg P. 1991; Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proceedings of the National Academy of Sciences, USA 88:5326–5330
    [Google Scholar]
80. Maitra R. K., Ahmad N., Holland S. M., Venkatesan S. 1991; Human immunodeficiency virus type I (HIV-1) provirus expression and LTR transcription are repressed in NEF-expressing cell lines. Virology 182:522–533
    [Google Scholar]
81. Mariani R., Skowronski J. 1993; CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. Proceedings of the National Academy of Sciences, USA 90:5549–5553
    [Google Scholar]
82. Matsuura Y., Maekawa M., Hattori S., Ikegami N., Hayashi A., Yamazaki S., Morita C., Takebe Y. 1991; Purification and characterization of human immunodeficiency virus type 1 nef gene product expressed by a recombinant baculovirus. Virology 184:580–586
    [Google Scholar]
83. Miller M. D., Warmerdam M. T., Gaston I., Greene W. C., Feinberg M. B. 1994; The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. Journal of Experimental Medicine 179:101–113
    [Google Scholar]
84. Miller M. D., Warmerdam M. T., Page K. A., Feinberg M. B., Greene W. C. 1995; Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gpl60 or viral entry. Journal of Virology 69:579–584
    [Google Scholar]
85. Murphy K. M., Sweet M. J., Ross I. L., Hume D. A. 1993; Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages. Journal of Virology 67:6956–6964
    [Google Scholar]
86. Murti K. G., Brown P. S., Ratner L., Garcia J. V. 1993; Highly localized tracks of human immunodeficiency virus type 1 Nef in the nucleus of cells of a human CD4+ T-cell line. Proceedings of the National Academy of Sciences, USA 90:11895–11899
    [Google Scholar]
87. Nebreda A. R., Bryan T., Segade F., Wingfield P., Venkatesan S., Santos E. 1991; Biochemical and biological comparison of HIV-1 NEF and ras gene products. Virology 183:151–159
    [Google Scholar]
88. Niederman T. M. J., Thielan B. J., Ratner L. 1989; Human immunodeficiency virus type I negative factor is a transcriptional silencer. Proceedings of the National Academy of Sciences, USA 86:1128–1132
    [Google Scholar]
89. Niederman T. M. J., Hu W., Ratner L. 1991; Simian immunodeficiency virus negative factor suppresses the level of viral mRNA in COS cells. Journal of Virology 65:3538–3546
    [Google Scholar]
90. Niederman T. M., Garcia J. V., Hastings W. R., Luria S., Ratner L. 1992; Human immunodeficiency virus type 1 Nef protein inhibits NF- _k b induction in human T cells. Journal of Virology 66:6213–6219
    [Google Scholar]
91. Niederman T. M. J., Hastings W. R., Luria S., Bandres J. C., Ratner L. 1993; HIV-1 nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells. Virology 194:338–344
    [Google Scholar]
92. Otake K., Fujii Y., Nakaya T., Nishino Y., Zhong Q., Fujinaga K., Kameoka M., Ohki K., Ikuta K. 1994; The carboxyl-terminal region of HIV-1 Nef protein is a cell surface domain that can interact with CD4 + T cells. Journal of Immunology 153:5826–5837
    [Google Scholar]
93. Ovod V., Lagerstedt A., Ranki A., Gombert F. O., Spohn R., Tahtinen M., Jung G., Krohn K. J. 1992; Immunological variation and immunohistochemical localization of HIV-1 Nef demonstrated with monoclonal antibodies. AIDS 6:25–34
    [Google Scholar]
94. Ranki A., Jarvinen K., Valle S. L., Nurmilaakso P., Krohn K. 1990; Antibodies to recombinant HIV-1 nef protein detected in HIV-1 infection as well as in nonrisk individuals. Journal of Acquired Immunodeficiency Syndromes 3:348–355
    [Google Scholar]
95. Resh M. D. 1994; Myristylation and palmitylation of Src family members: the fats of the matter. Cell 76:411–413
    [Google Scholar]
96. Rhee S. S., Marsh J. W. 1994a; HIV-1 Nef activity in murine T cells: CD4 modulation and positive enhancement. Journal of Immunology 152:5128–5134
    [Google Scholar]
97. Rhee S. S., Marsh J. W. 1994b; Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. Journal of Virology 68:5156–5163
    [Google Scholar]
98. Robert-Guroff M., Popovic M., Gartner S., Markham P., Gallo R. C., Reitz M. S. 1990; Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type I in infected lymphocytes and macrophages. Journal of Virology 64:3391–3398
    [Google Scholar]
99. Rossi F., Gallina A., Milanesi G. 1996; Nef-CD4 physical interaction sensed with the yeast two-hybrid system. Virology 217:397–403
    [Google Scholar]
100. Rud E. W., Yon J. R., Larder B. A., Clarke B. E., Cook N., Cranage M. P. 1992; Infectious molecular clones of SIVmac32H: Nef deletion controls ability to reisolate virus from rhesus macaques. In Vaccines ′92: Modem Approaches to New Vaccines including Prevention of AIDS pp 229–235 Edited by Brown F., Chanock R. M., Ginsberg H. G., Lemer R. A. New York: Cold Spring Harbor Laboratory Press;
     [Google Scholar]
101. RyanGraham M. A., Peden K. W. C. 1995; Both virus and host components are important for the manifestation of a nef – phenotype in HIV-1 and HIV-2. Virology 213:158–168
     [Google Scholar]
102. Saksela K., Cheng G., Baltimore D. 1995; Proline-rich (Pxxp) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef + viruses but not for down-regulation of CD4. EMBO Journal 14:484–491
     [Google Scholar]
103. Salghetti S., Mariani R., Skowronski J. 1995; Human immunodeficiency virus type 1 Nef and p56 (Lck) protein-tyrosine kinase interact with a common element in CD4 cytoplasmic tail. Proceedings of the National Academy of Sciences, USA 92:349–353
     [Google Scholar]
104. Samuel K. P., Seth A., Konopka A., Lutenberger J. A., Papas T. S. 1987; The 3′-orf protein of human immunodeficiency virus shows structural homology with the phosphorylation domain of human interleukinX-2 receptor and the ATP-binding site of the protein kinase family. FEBS Letters 218:81–86
     [Google Scholar]
105. Sanfridson A., Cullen B. R., Doyle C. 1994; The simian immunodeficiency virus Nef protein promotes degradation of CD4 in human T cells. Journal of Biological Chemistry 269:3917–3920
     [Google Scholar]
106. Sawai E. T., Baur A., Struble H., Peterlin B. M., Levy J. A., Cheng Mayer C. 1994; Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proceedings of the National Academy of Sciences, USA 91:1539–1543
     [Google Scholar]
107. Sawai E. T., Baur A. S., Peterlin B. M., Levy J. A., Cheng Mayer C. 1995; A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. Journal of Biological Chemistry 270:15307–15314
     [Google Scholar]
108. Schwartz O., Arenzana Seisdedos F., Heard J. M., Danos O. 1992; Activation pathways and human immunodeficiency virus type 1 replication are not altered in CD4 + T cells expressing the nef protein. AIDS Research and Human Retroviruses 8:545–551
     [Google Scholar]
109. Schwartz O., Dautryvarsat A., Goud B., Marechal V., Subtil A., Heard J., Danos O. 1995; Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes. Journal of Virology 69:528–533
     [Google Scholar]
110. Schwartz O., Marechal V., Le Gall S., Lemonnier F., Heard J. M. 1996; Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nature Medicine 2:338–342
     [Google Scholar]
111. Shugars D. C., Smith M. S., Glueck D. H., Nantermet P. V., Seillier-Moiseiwitsch F., Swanstrom R. 1993; Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo . Journal of Virology 67:4639–4650
     [Google Scholar]
112. Spina C. A., Kwoh T. J., Chowers M. Y., Guatelli J. C., Richman D. D. 1994; The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. Journal of Experimental Medicine 179:115–123
     [Google Scholar]
113. Stevenson M. 1996; Portals of entry: uncovering HIV nuclear transport pathways. Trends in Cell Biology 6:9–15
     [Google Scholar]
114. Tanaka T., Ames J. B., Harvey T. S., Stryer L., Ikura M. 1995; Sequestration of the membrane-targeting myristoyl group of recoverin in the calcium-free state. Nature 376:444–447
     [Google Scholar]
115. Terwilliger E., Sodroski J. G., Rosen C. A., Haseltine W. A. 1986; Effects of mutations within the 3′orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity. Journal of Virology 60:754–760
     [Google Scholar]
116. Unger R. E., Marthas M. L., Pratt Lowe E., Padrid P. A., Luciw P. A. 1992; The nef gene of simian immunodeficiency virus SIVmacIA11. Journal of Virology 66:5432–5442
     [Google Scholar]
117. Whatmore A. M., Cook N., Hall G. A., Sharpe S., Rud E. W., Cranage M. P. 1995; Repair and evolution of Nef in vivo modulates simian immunodeficiency virus virulence. Journal of Virology 69:5117–5123
     [Google Scholar]
118. Yu G., Felsted R. L. 1992; Effect of myristoylation on p27 nef subcellular distribution and suppression of HIV-LTR transcription. Virology 187:46–55
     [Google Scholar]
119. Zazopoulos E., Haseltine W. A. 1993; Effect of nef alleles on replication of human immunodeficiency virus type I. Virology 194:20–27
     [Google Scholar]
120. Zheng J., Knighton D. R., Xuong N. H., Taylor S. S., Sowadski J. M., Eyck L. F. T. 1993; Crystal structures of the myristylated catalytic subunit of cAMP-dependent protein kinase reveal open and closed conformations. Protein Science 2:1559–1573
     [Google Scholar]
121. Zhou W., Parent L. J., Wills J. W., Resh M. D. 1994; Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 gag protein which interacts with acidic phospholipids. Journal of Virology 68:2556–2569
     [Google Scholar]